The United States of America’s Food & Drug Administration has at last revoked the restrictions on bi and gay men donating blood.

The rules made sense in the 1980s when introduced in the face of HIV and AIDS, with no treatment options and – in those days – the overwhelming majority of cases among bi and gay men.

In future all prospective blood donors in the US will answer a series of individual, risk-based questions to determine eligibility. Prospective donors who report having a new sexual partner, or more than one sexual partner in the past three months, and anal sex in the past three months, would be deferred to reduce the likelihood of donations by individuals with new or recent HIV infection who may be in the window period for detection of HIV by nucleic acid testing.

In short: recognising risk is about behaviour not orientation.

In the announcement they observe that they now recommend:

(A)ssessing blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV. These questions will be the same for every donor, regardless of sexual orientation, sex or gender. Blood establishments may now implement these recommendations by revising their donor history questionnaires and procedures.

This updated policy is based on the best available scientific evidence and is in line with policies in place in countries like the United Kingdom and Canada. It will potentially expand the number of people eligible to donate blood, while also maintaining the appropriate safeguards to protect the safety of the blood supply.

“The FDA has worked diligently to evaluate our policies and ensure we had the scientific evidence to support individual risk assessment for donor eligibility while maintaining appropriate safeguards to protect recipients of blood products. The implementation of these recommendations will represent a significant milestone for the agency and the LGBTQI+ community,” said Peter Marks, M.D., PhD., director of the FDA’s Center for Biologics Evaluation and Research.

“The FDA is committed to working closely with the blood collection industry to help ensure timely implementation of the new recommendations and we will continue to monitor the safety of the blood supply once this individual risk-based approach is in place.”

This policy shift ends the time-based deferrals and screening questions specific to men who have sex with men (MSM) and women who have sex with MSM that had been in place in recent years after the lifetime ban on blood donation was revoked.